Document is current
Any future updates will be listed below
-
Authors
Leonard, Maureen M.
Karathia, Hiren
Pujolassos, Meritxell
Troisi, Jacopo
Valitutti, Francesco
Subramanian, Poorani
Camhi, Stephanie
Kenyon, Victoria
Colucci, Angelo
Serena, Gloria
Cucchiara, Salvatore
Montuori, Monica
Malamisura, Basilio
Francavilla, Ruggiero
Elli, Luca
Fanelli, Brian
Colwell, Rita
Hasan, Nur
Zomorrodi, Ali R.
Fasano, Alessio https://orcid.org/0000-0002-2134-0261
,
Piemontese, Pasqua
Calvi, Angela
Baldassarre, Mariella
Norsa, Lorenzo
Trovato, Chiara Maria
Raguseo, Celeste Lidia
Passaro, Tiziana
Roggero, Paola
Crocco, Marco
Morelli, Annalisa
Perrone, Michela
Chieppa, Marcello
Scala, Giovanni
Lionetti, Maria Elena
Catassi, Carlo
Serretiello, Adelaide
Vecchi, Corrado
de Villsante, Gemma Castillejo
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (5R01DK104344-04, 1K23DK122127-01, F32DK109620)
Thrasher Research Fund
Nutrition Obesity Research Center at Harvard University
- License Information
-
More Information
Article History
Received: 14 February 2020
Accepted: 10 August 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: Written informed consent was obtained from the parents of infants included in the study according to the standards outlined and approved by the Partners Human Research Committee Institutional Review Board.
: AF is a stockholder at Alba Therapeutics, serves as a consultant for Inova Diagnostics and Innovate Biopharmaceuticals, is an advisory board member for Axial Biotherapeutics and Ubiome, and has a speaker agreement with Mead Johnson Nutrition. MML serves as a consultant to HealthMode and Anokion, has a speaker agreement with Takeda Pharmaceuticals, and performs sponsored research with Glutenostics LLC. HK is a former employee, BF is a current employee, PS is a consultant, and RRC and NAH are stockholders at CosmosID Inc. Other authors have declared no competing interests exist.
